Free Trial

OPKO Health (OPK) News Today

OPKO Health logo
$1.25 -0.04 (-2.73%)
Closing price 05/7/2025 03:59 PM Eastern
Extended Trading
$1.26 +0.01 (+1.20%)
As of 05/7/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OPK Latest News

OPKO Health, Inc. stock logo
Voya Investment Management LLC Has $1.85 Million Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)
Voya Investment Management LLC reduced its holdings in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 39.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,255,034 shares of the biotechnology company's stock
OPKO Health (NASDAQ:OPK) Rating Lowered to "Sell" at StockNews.com
OPKO Health, Inc. stock logo
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC
Barclays PLC raised its stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 68.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 916,368 shares of the biotechnology company's stock after buying an additional 373,032 shar
OPKO Health, Inc. stock logo
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright dropped their Q2 2025 earnings estimates for OPKO Health in a report issued on Thursday, May 1st. HC Wainwright analyst Y. Chen now expects that the biotechnology company will post earnings of ($0.10) per share for the quart
Q2 Earnings Estimate for OPKO Health Issued By HC Wainwright
Q1 2025 OPKO Health Inc Earnings Call
OPKO Health, Inc. stock logo
Marshall Wace LLP Buys 825,143 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Marshall Wace LLP raised its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 856.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 921,487 shares of the biotechnology company's stock after purchasing an additional 825,143 shares during the quarter.
OPKO Health: Q1 Earnings Snapshot
OPKO Health, Inc. stock logo
Invesco Ltd. Sells 4,475,485 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Invesco Ltd. trimmed its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 74.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,554,489 shares of the biotechnology company's stock after sell
OPKO Health, Inc. stock logo
OPKO Health, Inc. (NASDAQ:OPK) Sees Large Decline in Short Interest
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 34,960,000 shares, a decline of 70.0% from the March 31st total of 116,490,000 shares. Approximately 11.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,900,000 shares, the days-to-cover ratio is presently 7.1 days.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. initiated coverage on shares of OPKO Health in a report on Friday. They issued a "neutral" rating on the stock.
Opko Health initiated with a Neutral at JPMorgan
OPKO Health, Inc. stock logo
OPKO Health (OPK) Projected to Post Earnings on Wednesday
OPKO Health (NASDAQ:OPK) will be releasing its Q1 2025 earnings after the market closes on Wednesday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-30-opko-health-inc-stock/)
OPKO Health, Inc. stock logo
Altshuler Shaham Ltd Purchases Shares of 1,411,019 OPKO Health, Inc. (NASDAQ:OPK)
Altshuler Shaham Ltd acquired a new stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,411,019 shares of the biotechnology
OPKO Health, Inc. stock logo
Investors Buy Large Volume of OPKO Health Call Options (NASDAQ:OPK)
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 5,038 call options on the stock. This represents an increase of approximately 101% compared to the average volume of 2,501 call options.
OPKO Health, Inc. stock logo
Norges Bank Buys New Stake in OPKO Health, Inc. (NASDAQ:OPK)
Norges Bank bought a new stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,127,468 shares of the biotechnology company's stock, valued at approximately $1,657,000. Norges
OPKO Health, Inc. stock logo
Q3 Earnings Forecast for OPKO Health Issued By HC Wainwright
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for OPKO Health in a research note issued to investors on Monday, April 7th. HC Wainwright analyst Y. Chen now anticipates that the biotechnology company will po
OPKO Health, Inc. stock logo
OPKO Health, Inc. (NASDAQ:OPK) CEO Acquires $185,000.00 in Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 125,000 shares of the stock in a transaction dated Tuesday, April 8th. The shares were bought at an average price of $1.48 per share, with a total value of $185,000.00. Following the completion of the transaction, the chief executive officer now directly owns 213,876,448 shares of the company's stock, valued at $316,537,143.04. The trade was a 0.06 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
OPKO Health, Inc. stock logo
HC Wainwright Reiterates Buy Rating for OPKO Health (NASDAQ:OPK)
HC Wainwright restated a "buy" rating and issued a $3.00 price objective on shares of OPKO Health in a research note on Monday.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Sees Strong Trading Volume Following Insider Buying Activity
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume After Insider Buying Activity
OPKO Health, Inc. stock logo
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Up 24.1% in March
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 111,000,000 shares, an increase of 24.1% from the February 28th total of 89,470,000 shares. Based on an average daily trading volume, of 4,640,000 shares, the short-interest ratio is presently 23.9 days. Currently, 36.6% of the company's stock are short sold.
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 100,000 shares of the business's stock in a transaction dated Tuesday, April 1st. The stock was bought at an average price of $1.65 per share, for a total transaction of $165,000.00. Following the purchase, the chief executive officer now owns 213,751,448 shares in the company, valued at approximately $352,689,889.20. This represents a 0.05 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Piper Sandler Remains a Buy on Opko Health (OPK)
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 150,000 shares of OPKO Health stock in a transaction dated Friday, March 28th. The stock was acquired at an average price of $1.70 per share, with a total value of $255,000.00. Following the acquisition, the chief executive officer now directly owns 213,651,448 shares of the company's stock, valued at approximately $363,207,461.60. This represents a 0.07 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
OPKO Health, Inc. stock logo
Charles Schwab Investment Management Inc. Cuts Position in OPKO Health, Inc. (NASDAQ:OPK)
Charles Schwab Investment Management Inc. lowered its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 17.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,497,406 shares of the biotechnology company's s
OPKO Health, Inc. stock logo
Zacks Research Weighs in on OPKO Health FY2027 Earnings
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Zacks Research issued their FY2027 earnings estimates for shares of OPKO Health in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst R. Department anticipates that the biot
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Given Buy Rating at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $3.00 target price on shares of OPKO Health in a report on Wednesday.
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 200,000 shares of the company's stock in a transaction dated Monday, March 17th. The shares were acquired at an average cost of $1.74 per share, with a total value of $348,000.00. Following the acquisition, the chief executive officer now directly owns 213,501,448 shares of the company's stock, valued at approximately $371,492,519.52. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.

OPK Media Mentions By Week

OPK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPK
News Sentiment

0.21

0.64

Average
Medical
News Sentiment

OPK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPK Articles
This Week

13

4

OPK Articles
Average Week

Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OPK) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners